BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1074 related articles for article (PubMed ID: 10969817)

  • 1. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
    Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
    Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion.
    Nithipatikom K; Isbell MA; Lindholm PF; Kajdacsy-Balla A; Kaul S; Campell WB
    Clin Exp Metastasis; 2002; 19(7):593-601. PubMed ID: 12498388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer.
    Yao M; Lam EC; Kelly CR; Zhou W; Wolfe MM
    Br J Cancer; 2004 Feb; 90(3):712-9. PubMed ID: 14760389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulative effect of cadmium on prostaglandin E2 production in primary mouse osteoblastic cells.
    Miyahara T; Tonoyama H; Watanabe M; Okajima A; Miyajima S; Sakuma T; Nemoto N; Takayama K
    Calcif Tissue Int; 2001 Mar; 68(3):185-91. PubMed ID: 11351503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
    Rozic JG; Chakraborty C; Lala PK
    Int J Cancer; 2001 Aug; 93(4):497-506. PubMed ID: 11477553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
    Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of arachidonic acid metabolism decreases tumor cell invasion and matrix metalloproteinase expression.
    Koontongkaew S; Monthanapisut P; Saensuk T
    Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):100-8. PubMed ID: 20654727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
    J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-steroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 expression via repression of transcription in lung cancer cells.
    Pan MR; Chuang LY; Hung WC
    FEBS Lett; 2001 Nov; 508(3):365-8. PubMed ID: 11728453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line.
    Liu XH; Kirschenbaum A; Yao S; Stearns ME; Holland JF; Claffey K; Levine AC
    Clin Exp Metastasis; 1999; 17(8):687-94. PubMed ID: 10919714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.
    Liu XH; Yao S; Kirschenbaum A; Levine AC
    Cancer Res; 1998 Oct; 58(19):4245-9. PubMed ID: 9766645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonic acid inhibits osteoblast differentiation through cytosolic phospholipase A2-dependent pathway.
    Yoshida K; Shinohara H; Haneji T; Nagata T
    Oral Dis; 2007 Jan; 13(1):32-9. PubMed ID: 17241427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 24R,25-(OH)(2)D(3) mediates its membrane receptor-dependent effects on protein kinase C and alkaline phosphatase via phospholipase A(2) and cyclooxygenase-1 but not cyclooxygenase-2 in growth plate chondrocytes.
    Schwartz Z; Sylvia VL; Del Toro F; Hardin RR; Dean DD; Boyan BD
    J Cell Physiol; 2000 Mar; 182(3):390-401. PubMed ID: 10653606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line.
    Liu XH; Kirschenbaum A; Lu M; Yao S; Dosoretz A; Holland JF; Levine AC
    J Biol Chem; 2002 Dec; 277(51):50081-6. PubMed ID: 12401798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 1alpha,25-(OH)(2)D(3) on rat growth zone chondrocytes are mediated via cyclooxygenase-1 and phospholipase A(2).
    Sylvia VL; Del Toro F; Dean DD; Hardin RR; Schwartz Z; Boyan BD
    J Cell Biochem Suppl; 2001; Suppl 36():32-45. PubMed ID: 11455568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase inhibitors not inhibit resting lung cancer A549 cell proliferation.
    Duan W; Zhang L
    Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):317-21. PubMed ID: 16618538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells.
    Abiru S; Nakao K; Ichikawa T; Migita K; Shigeno M; Sakamoto M; Ishikawa H; Hamasaki K; Nakata K; Eguchi K
    Hepatology; 2002 May; 35(5):1117-24. PubMed ID: 11981761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility.
    Nie D; Che M; Zacharek A; Qiao Y; Li L; Li X; Lamberti M; Tang K; Cai Y; Guo Y; Grignon D; Honn KV
    Am J Pathol; 2004 Feb; 164(2):429-39. PubMed ID: 14742249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
    Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.